Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
Not yet recruiting · NCT06748950 · Registry updated 2025-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling | Acid-Base Imbalance, Bipolar and Related Disorders, Insulin Resistance, Ketosis, Nutritional and Metabolic Diseases, Schizophrenia Spectrum and Other Psychotic Disorders, acidosis disorder, bipolar disorder, depressive disorder, glucose metabolism disease, hyperinsulinism, major depressive disorder, metabolic disease, mood disorder, psychiatric disorder, schizophrenia | Not yet recruiting | Not applicable | 2025-05-16 | NCT06748950 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford University | Palo Alto | United States | 161 |